313 related articles for article (PubMed ID: 17785803)
1. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival.
Shen L; Jin Y; Freeman GJ; Sharpe AH; Dana MR
J Immunol; 2007 Sep; 179(6):3672-9. PubMed ID: 17785803
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
3. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
[TBL] [Abstract][Full Text] [Related]
4. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M
J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517
[TBL] [Abstract][Full Text] [Related]
5. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
6. PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.
Tanaka K; Albin MJ; Yuan X; Yamaura K; Habicht A; Murayama T; Grimm M; Waaga AM; Ueno T; Padera RF; Yagita H; Azuma M; Shin T; Blazar BR; Rothstein DM; Sayegh MH; Najafian N
J Immunol; 2007 Oct; 179(8):5204-10. PubMed ID: 17911605
[TBL] [Abstract][Full Text] [Related]
7. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
[TBL] [Abstract][Full Text] [Related]
8. Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1.
Fiorina P; Jurewicz M; Vergani A; Petrelli A; Carvello M; D'Addio F; Godwin JG; Law K; Wu E; Tian Z; Thoma G; Kovarik J; La Rosa S; Capella C; Rodig S; Zerwes HG; Sayegh MH; Abdi R
J Immunol; 2011 Jan; 186(1):121-31. PubMed ID: 21131428
[TBL] [Abstract][Full Text] [Related]
9. Role of B7-H1 in immune privilege of the eye.
Hori J
J Nippon Med Sch; 2008 Feb; 75(1):56-7. PubMed ID: 18360084
[No Abstract] [Full Text] [Related]
10. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time.
Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW
J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773
[TBL] [Abstract][Full Text] [Related]
11. Programmed death-1 targeting can promote allograft survival.
Ozkaynak E; Wang L; Goodearl A; McDonald K; Qin S; O'Keefe T; Duong T; Smith T; Gutierrez-Ramos JC; Rottman JB; Coyle AJ; Hancock WW
J Immunol; 2002 Dec; 169(11):6546-53. PubMed ID: 12444166
[TBL] [Abstract][Full Text] [Related]
12. Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation.
El Annan J; Goyal S; Zhang Q; Freeman GJ; Sharpe AH; Dana R
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3418-23. PubMed ID: 20019373
[TBL] [Abstract][Full Text] [Related]
13. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
[TBL] [Abstract][Full Text] [Related]
14. Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles.
Menke J; Lucas JA; Zeller GC; Keir ME; Huang XR; Tsuboi N; Mayadas TN; Lan HY; Sharpe AH; Kelley VR
J Immunol; 2007 Dec; 179(11):7466-77. PubMed ID: 18025191
[TBL] [Abstract][Full Text] [Related]
15. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
[TBL] [Abstract][Full Text] [Related]
16. B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism.
Matsumoto K; Inoue H; Nakano T; Tsuda M; Yoshiura Y; Fukuyama S; Tsushima F; Hoshino T; Aizawa H; Akiba H; Pardoll D; Hara N; Yagita H; Azuma M; Nakanishi Y
J Immunol; 2004 Feb; 172(4):2530-41. PubMed ID: 14764726
[TBL] [Abstract][Full Text] [Related]
17. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].
Taylor PA; Lees CJ; Fournier S; Allison JP; Sharpe AH; Blazar BR
J Immunol; 2004 Jan; 172(1):34-9. PubMed ID: 14688306
[TBL] [Abstract][Full Text] [Related]
18. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
Wang L; Han R; Hancock WW
Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549
[TBL] [Abstract][Full Text] [Related]
19. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
[TBL] [Abstract][Full Text] [Related]
20. A novel function for programmed death ligand-1 regulation of angiogenesis.
Jin Y; Chauhan SK; El Annan J; Annan JE; Sage PT; Sharpe AH; Dana R
Am J Pathol; 2011 Apr; 178(4):1922-9. PubMed ID: 21435468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
